Detalhe da pesquisa
1.
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy.
Cell
; 186(16): 3333-3349.e27, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490916
2.
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1891-1902, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295337
3.
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1903-1930, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306595
4.
Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.
PLoS Genet
; 18(10): e1010463, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36288392
5.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
6.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
N Engl J Med
; 381(24): 2315-2326, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826340
7.
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia.
Ann Hematol
; 101(10): 2179-2193, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941390
8.
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Haematologica
; 106(9): 2397-2404, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732354
9.
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
Ann Hematol
; 100(8): 2023-2029, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110462
10.
Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
Cancer
; 126(2): 304-310, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626339
11.
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.
Blood
; 131(3): 311-322, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122757
12.
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
Blood
; 131(13): 1464-1475, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348129
13.
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Invest New Drugs
; 38(5): 1472-1482, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172489
14.
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.
Blood
; 130(18): 2027-2031, 2017 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827408
15.
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
N Engl J Med
; 373(10): 920-8, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332546
16.
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Blood
; 128(6): 774-82, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121472
17.
The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
PLoS Genet
; 11(4): e1005144, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25919613
18.
TKI vs relapse after HSCT: is the jury still out?
Blood
; 136(15): 1705-1706, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031524
19.
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Cytotherapy
; 19(2): 235-249, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27887866
20.
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
Ann Hematol
; 96(6): 895-904, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331964